Association pour l'Etude des Fonctions Digestives Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2007
NCT00561535
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Association pour l'Etude des Fonctions Digestives (AEFD)

Active Ingredients

Drugs in Phase 2 Trials (2)

deferasirox (exjade) (1 trial)

lactobacillus farciminis (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 2)

Irritable Bowel Syndrome (Phase 2)

Porphyria Cutanea Tarda (Phase 2)

Porphyria, Erythropoietic (Phase 2)

Porphyrias (Phase 2)

Porphyrias, Hepatic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2